Dose-Response Relationship, Immunologic
"Dose-Response Relationship, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.
Descriptor ID |
D004306
|
MeSH Number(s) |
G12.300
|
Concept/Terms |
Dose-Response Relationship, Immunologic- Dose-Response Relationship, Immunologic
- Dose Response Relationship, Immunologic
- Immunologic Dose-Response Relationship
- Dose-Response Relationships, Immunologic
- Immunologic Dose Response Relationship
- Immunologic Dose-Response Relationships
- Relationships, Immunologic Dose-Response
- Relationship, Immunologic Dose-Response
- Relationship, Immunologic Dose Response
|
Below are MeSH descriptors whose meaning is more general than "Dose-Response Relationship, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Dose-Response Relationship, Immunologic".
This graph shows the total number of publications written about "Dose-Response Relationship, Immunologic" by people in this website by year, and whether "Dose-Response Relationship, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2004 | 0 | 2 | 2 |
2005 | 0 | 1 | 1 |
2006 | 0 | 2 | 2 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 1 | 16 | 17 |
2018 | 1 | 9 | 10 |
2019 | 0 | 2 | 2 |
2020 | 0 | 7 | 7 |
2021 | 0 | 8 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Dose-Response Relationship, Immunologic" by people in Profiles.
-
Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice. Sci Rep. 2021 08 04; 11(1):15799.
-
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers. Nat Commun. 2021 07 29; 12(1):4617.
-
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination. Proc Natl Acad Sci U S A. 2021 07 13; 118(28).
-
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP. J Exp Med. 2021 07 05; 218(7).
-
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 12; 21(12):1645-1653.
-
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination. Nat Commun. 2021 06 08; 12(1):3449.
-
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature. 2021 07; 595(7869):718-723.
-
Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19. Viruses. 2021 05 22; 13(6).
-
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021 06; 22(6):765-778.
-
Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor-recipient differences in concentration of neutralizing antibodies. Clin Microbiol Infect. 2021 Jul; 27(7):987-992.